-+ 0.00%
-+ 0.00%
-+ 0.00%

Galmed Pharmaceuticals Granted New Patent for Combination of Aramchol and Rezdiffra (Resmetirom) for MASH Treatment

Reuters·12/04/2025 13:30:38

Please log in to view news